0001437749-17-000152.txt : 20170104
0001437749-17-000152.hdr.sgml : 20170104
20170104161505
ACCESSION NUMBER: 0001437749-17-000152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byrne Thomas E
CENTRAL INDEX KEY: 0001663220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 17505550
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER NAME:
FORMER CONFORMED NAME: Byrne Thomas S
DATE OF NAME CHANGE: 20160108
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-01-03
0001053691
Diffusion Pharmaceuticals Inc.
DFFN
0001663220
Byrne Thomas E
2020 AVON COURT, SUITE 4
CHARLOTTESVILLE
VA
22902
1
General Counsel
Stock Option (Right to Buy)
2.26
2017-01-03
4
A
0
4673
0
A
2027-01-03
Common Stock
4673
4673
D
The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on December 31, 2019.
/s/ Ben Shealy, attorney-in-fact for Thomas Byrne
2017-01-04